Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

The Pharmaceutical "Business with Disease"

Up to date news and comment about the "Business with Disease".

China to introduce an online healthcare corruption 'blacklist'

December 27, 2013

China will in 2014 introduce a blacklist of drug makers and medical device manufacturers found to have paid bribes as it extends a crackdown on graft in the healthcare sector. Healthcare departments will compile lists of offending manufacturers, agents and individuals, which will be published online, the National Health and Family Planning Commission said on Friday. The list will come into effect from the beginning of March. Firms appearing on the list once will be banned for two years from selling within the region where they were implicated.
Read article in the South China Morning Post (China)

Britain becomes statins capital of Europe according to study
'Indolent' lifestyles turn Britain into the statins capital of Europe

December 25, 2013

Britain has become the "statins capital" of Europe - and has the second highest prescribing levels in the Western world for the drugs to protect against strokes and heart attacks, an international study has found.
Read article in the Daily Telegraph (UK)

Comment: Research shows that statins raise the risk of developing cataracts; breast cancer; muscular injuries and muscle pain; diabetes; kidney problems; osteoarthritis of the knee; peripheral nerve damage; calcification of the coronary arteries; eye damage and fatigue. To learn how high cholesterol levels can be eradicated naturally, without statins, visit the Cellular Health section of our Foundation website.

Using Aspirin To Prevent Heart Disease? You May Want To Reconsider; Study Shows Risks Outweigh Benefits

December 20, 2013

A review of recent studies suggests aspirin might do more harm than good as a preventive health measure for adults with no symptoms of heart disease. Investigators in the UK looked at 27 studies published between 2008 and 2012, including nine randomized clinical trials.
Read article at medicaldaily.com (USA)

Comment: Research shows that regular use of aspirin increases the risk of developing Crohn's disease; irregular heart rhythm; erectile dysfunction, hearing loss and age-related macular degeneration. To learn how cardiovascular disease can be eradicated naturally, without aspirin, visit the Cellular Health section of our Foundation website.

Warfarin doubles risk of stroke in first week
for irregular heartbeat sufferers

December 19, 2013

Warfarin, a drug taken by hundreds of thousand of people, has been found to more than double the risk of a stroke in the first week of taking the medication.
Read article in the Daily Telegraph (UK)

The Selling of Attention Deficit Disorder

December 14, 2013

After more than 50 years leading the fight to legitimize attention deficit hyperactivity disorder, Keith Conners could be celebrating. Severely hyperactive and impulsive children, once shunned as bad seeds, are now recognized as having a real neurological problem. Doctors and parents have largely accepted drugs like Adderall and Concerta to temper the traits of classic A.D.H.D., helping youngsters succeed in school and beyond. But Dr. Conners did not feel triumphant this fall as he addressed a group of fellow A.D.H.D. specialists in Washington. He noted that recent data from the Centers for Disease Control and Prevention show that the diagnosis had been made in 15 percent of high school-age children, and that the number of children on medication for the disorder had soared to 3.5 million from 600,000 in 1990. He questioned the rising rates of diagnosis and called them "a national disaster of dangerous proportions."
Read article in the New York Times (USA)

Japan Probes Pharma Magazine Ads Masquerading As Articles

December 12, 2013

The Japanese government is investigating whether numerous magazine articles intended to attract cancer patient may actually have been nothing more than embellished advertisements for cancer medicines and that several drugmakers paid the publisher of a monthly magazine to run the information, according to The Yomiuri Shimbun.
Read article at pharmalive.com

Boehringer Is Fined Nearly $1M For Disappearing Documents

December 11, 2013

How much does it cost if potentially damaging documents disappear? How about $931,000? This is what Boehringer Ingelheim must pay in fines after a US federal court judge expressed dismay and outrage that the drugmaker failed to preserve "countless" files sought by patients who filed lawsuits claiming the Pradaxa bloodthinner caused excessive and, sometimes, fatal bleeding.
Read article at pharmalive.com

Comment: With Pradaxa having generated more than $1 billion in worldwide sales, and Boehringer Ingelheim's net sales for 2012 exceeding $19 billion, injured patients may perhaps now be feeling, upon learning of this fine, that a mere $1 million penalty for the loss of these potentially damaging documents is nowhere near enough.

NEJM editor: "No longer possible
to believe much of clinical research published"

December 11, 2013

Harvard Medical School's Dr. Marcia Angell is the author of The Truth About the Drug Companies: How They Deceive Us and What to Do About It. But more to the point, she's also the former Editor-in-Chief at the New England Journal of Medicine, arguably one of the most respected medical journals on earth. But after reading her article in the New York Review of Books called Drug Companies & Doctors: A Story of Corruption, one wonders if any medical journal on earth is worth anybody's respect anymore.
Read article at iranian.com

Comment: The drug industry portrays itself as fighting to prevent and eliminate diseases. Instead, however, it is extorting billions of dollars from governments worldwide and demanding blind obedience from hundreds of millions of patients. Moreover, it is not even a health industry, it is an investment business. While pretending to deliver health to the world, its entire existence is based on promoting diseases as multi-billion dollar markets for patented drugs. To learn the truth about the drug industry, visit the Pharma Facts website.

Acid-suppressing medications associated
with vitamin B12 deficiency

December 10, 2013

Use for 2 or more years of proton pump inhibitors and histamine 2 receptor antagonists (two types of acid-inhibiting medications) was associated with a subsequent new diagnosis of vitamin B12 deficiency, according to a study appearing in the December 11 issue of JAMA.
Read article at medicalxpress.com

Comment: Coming hot on the heels of the news that NSAID painkillers deplete levels of vitamin B6, it remains one of the pharmaceutical industry's biggest secrets that drugs deplete the body of vitamins, minerals and other essential micronutrients. Notably, therefore, a book published in 1999 by pharmacist and clinical nutritionist Ross Pelton PhD cited 459 published studies on this subject and identified around 150 classes of drugs that cause nutrient depletion.

Amish girl in Ohio will not be forced to resume chemo for cancer

December 7, 2013

A court-appointed guardian will stop trying to force an Amish girl with leukemia to resume chemotherapy against her Ohio parents' wishes, according to a court filing on Friday.
Read Reuters news report at yahoo.com

Comment: Hopefully, having apparently now recovered using natural remedies, this young girl will finally be left alone and allowed to get on with her life. Based upon its reactions to similar situations in the past, however, it may perhaps be naive to assume the trillion-dollar-a-year pharmaceutical 'business with disease' and its stakeholders will allow this to happen.

Glaxo CEO on U.K. China Trade Mission Amid Bribery Probe

December 2, 2013

GlaxoSmithKline Plc (GSK) Chief Executive Officer Andrew Witty joined U.K. Prime Minister David Cameron on a trade mission to China today as his company faces a corruption investigation in the country.
Read article at bloomberg.com

Comment: With Glaxo employees at risk of charges in this Chinese bribery probe, and U.K. Prime Minister David Cameron desperately trying to defend the company's business practices in the country, Witty's presence on this so-called "trade mission" shows that the British government's revealing 2005 report on 'The Influence of the Pharmaceutical Industry' has been well and truly buried.

Glaxo Sparks Fury Over Sign-On Bonus Demand

November 28, 2013

GlaxoSmithKline (GSK), Britain's biggest drugs company, has sparked fury among some of its biggest suppliers by demanding 'bonus' payments to continue working with the group.
Read article on the Sky News website (UK)

Five decades on, Spain court convicts thalidomide maker

November 20, 2013

A court ordered the German maker of the banned pregnancy drug thalidomide to compensate Spanish victims who suffered birth defects from it in the 1960s, in a ruling released Wednesday. The Spanish victims' group that brought the suit said it would be the first time ever that the German firm Grunenthal had been ruled responsible for the scandal, although it has already compensated some victims.
Read article at medicalxpress.com

Comment: Secret files obtained by the Sydney Morning Herald newspaper in Australia reveal that Grunenthal ignored and covered-up repeated warnings that thalidomide could damage unborn babies. To download legal documents containing these files, click here and here.

IMS Health Study Forecasts Global Spending on Medicines
to Reach $1 Trillion Threshold in 2014, Driven by Greater Access

November 19, 2013

Greater access to medicines by the world's rapidly expanding middle class, together with stronger economic prospects in developed nations, will bring total spending on medicines to the $1 trillion threshold in 2014 and to $1.2 trillion by 2017, according to new research released today by the IMS Institute for Healthcare Informatics.
Read press release at imshealth.com

Comment: With projected sales figures like these, it is worth keeping this information in mind the next time someone asks you to donate money to a charity supporting research into new drug treatments for cancer or other chronic diseases. In short: The fraudulent pharmaceutical "business with disease" is a trillion-dollar-a-year industry and is most definitely not in need of charitable donations to fund its toxic drug research and increase its profits.

Johnson & Johnson To Pay $2.5B To Settle Hip Replacement Suits

November 19, 2013

Johnson & Johnson says it will pay $2.5 billion to settle thousands of lawsuits brought by hip replacement patients who accuse the company of selling faulty implants that led to injuries and additional surgeries.
Read article on the Time magazine website (USA)

Comment: Given that Johnson & Johnson has only just agreed, in a separate settlement, to pay the US Justice Department more than $2.2bn to settle criminal and civil claims relating to its marketing techniques, one could be forgiven for wondering whether it could afford yet another payment of this sort. But with sales of around $67 billion for 2012 alone, the fact is that it can easily do so. Which begs the question: Are these settlements really enough? With the city of Chicago having also now filed a court petition against the company, accusing it of deceptive marketing, time will tell whether Johnson & Johnson's recent history of criminal investigations is set to continue.

Long-term oral contraceptive users are twice
as likely to have serious eye disease

November 18, 2013

Research presented today, at the 117th Annual Meeting of the American Academy of Ophthalmology in New Orleans, has found that women who have taken oral contraceptives for three or more years are twice as likely to suffer from glaucoma, one of the leading causes of blindness which affects nearly 60 million worldwide.
Read article at medicalxpress.com

Comment: Long-term intake of estrogen and other hormones – either as hormonal contraception or as replacement therapy during menopause – is well known to cause a depletion of vitamins and other essential cellular nutrients in the body. This is the reason why women taking contraceptives also have an increased risk for heart attacks, strokes and other forms of cardiovascular disease. In fact, this has been known since as long ago as 1972 when a study published in the scientific journal Nature reported that women taking hormonal contraceptives had significantly lower vitamin C blood levels than normal. To learn about clinical studies documenting the importance of micronutrients and nutrition in maintaining optimum eye health, visit the Worldwide Studies and Research page on our Foundation website.

Chicago Subpoenas J&J Over 'Deceptive' Opioid Marketing

November 15, 2013

In the latest imbroglio over prescription painkillers, the city of Chicago has filed a petition accusing Johnson & Johnson and its Janssen unit of deceptive marketing of two medicines – the Duragesic patch and Nucynta tablet – and wants the drugmaker to relinquish six years' worth of documents, Crain's Chicago Business writes.
Read article at pharmalive.com

FDA says new cholesterol drugs may not need outcome studies

November 14, 2013

Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug Administration said on Thursday.
Read Reuters news report at yahoo.com

Comment: After 25 years of duping mankind with the cholesterol fallacy, most patents on statins have now either expired or are about to. So the Pharma Cartel and its stakeholders in medicine are preparing to drum up the continuation of this fraud for yet another quarter of a century. Yet again, therefore, in a further continuation of the 'business with disease', the predictable side-effects will create still new drug markets for the additional diseases that will inevitably result from this reckless profit-seeking madness.

Don't Give More Patients Statins

November 13, 2013

On Tuesday, the American Heart Association and the American College of Cardiology issued new cholesterol guidelines that essentially declared, in one fell swoop, that millions of healthy Americans should immediately start taking pills — namely statins — for undefined health "benefits." This announcement is not a result of a sudden epidemic of heart disease, nor is it based on new data showing the benefits of lower cholesterol. Instead, it is a consequence of simply expanding the definition of who should take the drugs — a decision that will benefit the pharmaceutical industry more than anyone else.
Read article in the New York Times (USA)

Comment: Unknown to the millions of Americans who are about to be advised by their doctors that they need to start taking statins, the real reason these so-called 'guidelines' have been implemented is that a few years ago the pharma industry attempted, but failed, to have statins declared as 'over-the-counter' drugs. Significantly, therefore, of the 15 panelists that authored the new guidelines, six reported having recent or current ties to drugmakers that already sell or are developing cholesterol medications. To learn how cardiovascular disease can be eradicated naturally, without drugs, visit the Cellular Health section of our Foundation website.

NSAID Painkillers Found To Deplete Vitamin B-6 Levels

November 11, 2013

New research has determined that COX-inhibitors, which include numerous NSAIDs – Nonsteroidal anti-inflammatory drugs – reduce Vitamin B-6 levels within the body.
Read article at greenmedinfo.com

Comment: One of the biggest secrets in the drug industry is that pharmaceutical drugs deplete the body of vitamins, minerals and other essential micronutrients. Particularly notably, a book published in 1999 by pharmacist and clinical nutritionist Ross Pelton PhD cited 459 published studies on this subject and identified around 150 classes of drugs that cause nutrient depletion.

Swine flu pandemic media pundits with pharma links
more likely to talk up risks and promote drugs

November 11, 2013

Academics with links to the pharmaceutical industry were more likely to talk up the risks of the 2009-10 swine flu pandemic in the media and promote the use of drugs than those without these ties, finds research published online in the Journal of Epidemiology and Community Health.
Read article at medicalxpress.com

Comment: This finding is anything but surprising. Over the past century, the Pharma Cartel and its army of lobbyists have infiltrated all sectors of our society. In doing so, they have strategically built an intricate maze of manipulation, deception and control. In addition to endorsement of the pharmaceutical "business with disease" by doctors and other health professionals, the most important elements of this deception scheme include the manipulation of research so that patented synthetic drugs are perceived as "medicine", multi-million dollar advertising campaigns on television and in other mass media, and legislation brought about by pro-pharma regulatory agencies and politicians. To learn the truth about the swine flu scare, read this article.

ACE inhibitor drugs linked to kidney damage

November 6, 2013

Common drugs known as ACE inhibitors are linked to acute kidney injury in new study.
Read article in the Daily Telegraph (UK)

Over 2,500 Deaths During Indian Clinical Trials

November 5, 2013

KOLKATA - More than 2,500 Indians have died in the course of clinical trials in recent years, government figures reveal.
Read news report on the Inter Press Service News Agency website

Comment: Ultimately, the bottom line about the products of the Pharma Cartel is that there's no such thing as a safe drug.

Johnson & Johnson fined $2.2bn to settle drug cases

November 4, 2013

Drugs giant Johnson & Johnson has agreed to pay more than $2.2bn (£1.4bn) to settle allegations over its marketing techniques, the US justice department has said.
Read article on the BBC News website (UK)

Comment: At the press conference announcing this fine, Attorney General Eric Holder publicly and openly alleged that Johnson & Johnson and three of its subsidiaries marketed prescription drugs for uses that were never approved as safe and effective; that they paid kickbacks to physicians and pharmacies for prescribing and promoting drugs; and that they lined their pockets at the expense of American taxpayers, patients, and the private insurance industry. Explaining that the settlement also addresses allegations of conduct that recklessly put at risk the health of some of the most vulnerable members of society – including young children, the elderly, and the disabled – Holder described Johnson & Johnson’s conduct as shameful and unacceptable, adding that the company had displayed a reckless indifference to the safety of the American people. Notably, therefore, this fine is only the latest in a long list of scandals involving Johnson & Johnson that include criminal investigations, hiding data about a design flaw in a hip implant, and evidence suggesting it hired contractors to conduct a clandestine recall of one of its products without notifying consumers of the potential problems.

Ibuprofen no good in treating colds or sore throats

November 4, 2013

Questions have been raised about the advice given to patients with a cold and sore throat, in research published in the British Medical Journal. A study carried out by the University of Southampton showed that compared with paracetamol, ibuprofen or a combination of both ibuprofen and paracetamol provide no advantage for patients overall with respiratory tract infections (otherwise known as colds or sore throats).
Read article at medicalxpress.com

Comment: Contrary to what the pharmaceutical business with disease and its stakeholders in medicine and the media would have you believe, scientific research has shown that micronutrients and nutrition are effective against the common cold and other infectious diseases. To learn about the work being done at the Dr. Rath Research Institute in the area of infectious diseases, click here.

Novartis Faces Criminal Complaint Over Diovan Research In Japan

November 4, 2013

For Novartis, the embarrassing scandal over Diovan research in Japan has taken another turn for the worse. A non-governmental organization has filed a criminal complaint that accuses the drugmaker of using manipulated clinical trial data, which was carried out by several universities, to exaggerate the benefits of the widely used hypertension treatment in its advertising, according to Yomiuri Shimbun.
Read article at pharmalive.com

Scientists voice fears over ethics of drug trials remaining unpublished

October 29, 2013

Drug companies and other organisations that carry out clinical trials are violating their ethical obligation to the people who take part by failing to publish the results, scientists will argue on Wednesday.
Read article in The Guardian (UK)

Comment: The main reason why pharma companies hide the results of drug trials is that they show no clinical benefit whatsoever. Moreover, a huge body of pro-pharmaceutical medical literature is, in reality, the work not of independent scientists but of drug industry-sponsored writers. Drug companies such as GlaxoSmithKline, Wyeth, Eli Lilly & Co. and Merck have all been widely reported to engage in this highly unethical and deliberately misleading practice.

Barrow beautician died following chemotherapy, inquest hears

October 28, 2013

A beautician died from an infection and heart failure after chemotherapy, an inquest heard yesterday. Briony Hindle, 20, died at Furness General Hospital on August 11 with her parents at her bedside. Miss Hindle had a rare bone cancer, osteosarcoma, and had been treated at The Christie Hospital, in Manchester, for nine months. An inquest heard pathologist Dr Sanjeev Katti found the cause of death to be sepsis and chemotherapy-induced cardiomyopathy.
Read article on the North-West Evening Mail website (UK)

Comment: Tragic though this case is, the reality is that chemotherapy is a highly dangerous treatment that contributes to a quarter of all deaths from cancer. Worse still, and unbeknown to the vast majority of patients, the overall contribution of chemotherapy to 5-year cancer survival in adults has been estimated to be only 2.3% in Australia and 2.1% in the USA. To learn about natural health approaches to cancer that have been shown to block all key mechanisms that make it a deadly disease, click here. To learn why, after the banking and oil industries, the pharmaceutical “business with disease” is the next global industry fighting for the survival of its credibility, visit the Pharma Facts website.

Former Bristol-Myers Exec Gets One Year For Insider Trading

October 24, 2013

A former Bristol-Myers Squibb executive who pleaded guilty to insider trading was sentenced on Wednesday to one year in prison and a $10,000 fine. Robert Ramnarine, 46, a former executive director of pension and savings, bought stock options in three drugmakers that were targeted for acquisition, which yielded more than $311,000 in profits.
Read article at pharmalive.com

Academics Want University To Probe A Suicide In Seroquel Trial

October 22, 2013

What contributed to the 2004 death of Dan Markinson? This nagging question has been asked ever since the troubled 26-year old committed suicide while participating in a clinical trial that was run by University of Minnesota researchers. The ensuing years have produced a lawsuit by his mother and probes that went nowhere amid charges of conflicts of interest and mismanagement at the school.
Read article at pharmalive.com

Health Canada review of controversial acne drug kept secret
Blood clots in her lungs killed Marit McKenzie,
and a hospital pharmacist flagged an acne medication.
But Health Canada's review of the drug is secret.

October 19, 2013

Bruce McKenzie would like to know how a controversial acne drug suspected of killing his healthy teenage daughter this year has, in Health Canada's words, "benefits" that "continue to outweigh the risks." But the report that could explain how the federal agency arrived at this conclusion is a secret. It's one of more than 150 classified safety reviews completed by Health Canada this year alone.
Read article on the Toronto Star website (Canada)

Alemtuzumab authorised for treating MS:
29,000 Times the Price of Gold!

October 17, 2013

For a decade, the active ingredient Alemtuzumab (then trade name: MabCampath) was used to treat leukaemia. In order to increase profits, this indication was abandoned last year. The drug was authorised for the treatment of MS under the new name Lemtrada and is now being sold for a significantly higher price. In September, the EU commission issued an authorisation to the company Genzyme for treating Multiple Sclerosis with the active ingredient Alemtuzumab. Genzyme is part of the pharmaceutical enterprise Sanofi. The company Bayer was involved in the development of Alemtuzumab and receives a share of the profits.
Read press release at cbgnetwork.de (Germany)

GSK's Mark Reilly barred from leaving China

October 15, 2013

The British former chief of GlaxoSmithKline’s operation in China has returned to the country to “help” police with bribery investigations but has been barred from leaving, it can be disclosed.
Read article in the Daily Telegraph (UK)

Comment: With Glaxo’s sales in China now plunging as a result of this bribery probe, and U.S. authorities now investigating it as well, the company’s problems are mounting fast.

The Chinese Bribery Scandal Is Starting To Hurt Big Pharma

October 15, 2013

Ever since the bribery scandal in China erupted four months ago, there has been growing acceptance among multi-national drugmakers that the Chinese government probes into marketing practices were going to hurt business.
Read article at pharmalive.com

EU Spent $171 Billion on Cancer in 2009, Researchers Say

October 13, 2013

The European Union spent 126 billion euros ($171 billion) on cancer costs in 2009, according to a study by U.K. researchers that may help officials choose where to spend to fight disease. Health care accounted for 51 billion euros, or about 40 percent, of the spending, they wrote in the journal Lancet Oncology. Drugs accounted for 13.6 billion euros of the medical costs. Other expenses stemmed from care and lost productivity, according to the study funded by New York-based drugmaker Pfizer Inc.
Read article at bloomberg.com

Comment: Despite this huge sum of money, the fact is that none of it is being spent on eradicating cancer naturally. As such, with the total global economic impact of the five leading chronic diseases — cancer, diabetes, mental illness, heart disease, and respiratory disease — now expected to reach $47 trillion over the next 20 years, the pharmaceutical business model is clearly both morally and economically unsustainable.

Ohio Hospital Can Force Chemo on Amish Girl, Court Says

October 9, 2013

A court today is expected to give an attorney for the Children's Hospital in Akron, Ohio, temporary custody of a 10-year-old Amish girl so she can resume chemotherapy after her parents decided to stop the treatments.
Read article on the ABC News website (USA)

Comment: As we have said many times before, in order to enforce its “Business with Cancer” the Drug Cartel has to ensure that nobody – not even a young child – is able to escape its dictatorial grasp. In this situation, as this girl’s parents continue their fight to save her life using natural approaches, we are reminded yet again of the experiences of the parents of Dominik Feld. Speaking after Dominik’s death at the hands of pharmaceutical medicine in 2004, his mother movingly described how, to the drug industry’s stakeholders in the medical profession, their son’s interests were secondary to trying to show the world that Dr. Rath was wrong and that the results of his cancer research are false. For the time being, therefore, whilst Victory Over Cancer and a Cancer Free World are already now possible, the people of the world will have to continue to fight to make them a reality.

Former drug execs, 2 others plead guilty in insider trading scheme

October 8, 2013

NEWARK, New Jersey — Four people, including former executives at two drug companies, have pleaded guilty to running an insider trading scheme.
Read Associated Press news report at dailyjournal.net (USA)

Comment: With even business magazines such as Forbes now asking whether the pharma industry is addicted to fraud, and yet another drug company share manipulation probe currently getting underway in South Korea, it is not by accident that we use the term ‘Pharmaceutical Investment Business with Disease’. In the world of the ‘Business with Disease,’ profit and the accumulation of wealth are the main driving forces behind every decision taken. To the people who control these companies, it isn’t important how the profits (and hence the wealth) are generated, simply that they are.

How a marriage with big pharma ended in divorce

October 8, 2013

The abrupt termination last week of an umbrella group of leading drug companies, royal medical colleges and leading health organisations comes as no surprise to critics of the body’s pro-pharma statements. In March 2012 a group of 19 of Britain’s leading pharmaceutical and healthcare bodies published two documents that were meant to provide definitive guidance on the interaction between doctors and drug companies and transparency in clinical trials.
Read blog entry at pharmagossip.blogspot.nl

Comment: It is a proven fact that the British government is fully aware of the pervasive influence of the Drug Cartel. In April 2005 it published a revealing report entitled ‘The Influence of the Pharmaceutical Industry’. Compiled by a departmental select committee appointed by the British House of Commons, it examined the influence that the Drug Cartel has upon the practice of medicine and healthcare in the UK. Significantly, however, after being given only the briefest of attention in the British media, the report was effectively buried with the result that its key findings have been ignored.

Emails point to 'troubling' relationship between drug firms, regulators

October 6, 2013

Federal health industry regulators and executives of companies that make pain drugs have held private meetings at expensive hotels at least once a year since 2002 through an organization funded by the drug companies, according to emails obtained through public records requests and provided to the Journal Sentinel/MedPage Today. Each year a handful of drug companies have paid up to $35,000 each to send a representative to meetings of IMMPACT, where they could discuss clinical trial testing procedures with officials from the U.S. Food and Drug Administration and other government agencies.
Read article on the Milwaukee-Wisconsin Journal Sentinel website (USA)

Drug Companies’ Expansion Into Emerging Markets

October 1, 2013

Faced with declining prescription drug sales in the United States, and having lost patent protection for many profitable drugs, the drug industry is relying increasingly on new markets, such as China and other fast-developing countries, including those in Africa. That expansion, however, is oftentimes tainted by unsavory commercial practices.
Read article on the Epoch Times website

Tylenol’s Risks Not Fully Understood, Poll Shows

September 23, 2013

Americans have a spotty understanding of the risks of Tylenol, a nationwide poll conducted earlier this year shows.
Read article at propublica.org (USA)

EU body endorses 11 new drugs from Glaxo, Roche, J&J and others

September 20, 2013

A European Union regulator has recommended approval of 11 new drugs for a range of diseases such as HIV, breast cancer and diabetes.
Read article at fiercebiotech.com

Comment: Given the toxicities of these 11 drugs, it is particularly telling that, in order to protect the near-trillion dollar-a-yearBusiness with Disease’, the Brussels EU is simultaneously engaged in an ongoing and systematic effort to eliminate safe non-patentable natural health therapies, and information about them, across the entire European continent. To learn how currently proposed methodologies for assessing the supposed “risk” of consuming nutritional supplements are unscientific and deeply flawed, read this article.

Heart disease drug statins 'raise the risk of developing cataracts by 27%'

September 20, 2013

Millions of people who take statins to fight heart disease could be 27 per cent more likely to develop cataracts, researchers warn.
Read article in the Daily Mail (UK)

Digoxin Use Associated With Higher Risk of Death for Heart Failure Patients

September 20, 2013

Digoxin, a drug commonly used to treat heart conditions, was associated with a 72 percent higher rate of death among adults with newly diagnosed systolic heart failure, according to a Kaiser Permanente study that appears in the current online issue of Circulation: Cardiovascular Quality and Outcomes.
Read article at sciencedaily.com

Google joins the biotech-pharmaceutical industry, searching for the fountain of youth

September 19, 2013

Google has joined the search for the fountain of youth and ways to alleviate the problems of aging. The Internet giant, which has changed the world in other ways, announced Wednesday that it was starting a biotech research company called Calico that, "will focus on health and well-being, in particular the challenge of aging and associated diseases," according to the company statement.
Read article at philly.com (USA)

Comment: Given what we now know about Google, you should not hold your breath over this story or be taken in by the hype. Instead, just keep in mind that it is not in the financial interests of pharmaceutical companies to prevent health problems as the maintenance and expansion of diseases is a precondition for the industry’s financial growth. Contrary to the impression given by drug firms themselves, the pharmaceutical industry is an investment industry driven by the profits of its shareholders. Improving human health is not its driving force. To learn more about the main principles governing the ideology of the pharmaceutical industry, read ‘The Laws of the Pharmaceutical Industry’ on our Foundation website.

Elite US Army units stop taking anti-malarial drug

September 19, 2013

The top doctor for elite U.S. Army commandos has told troops to immediately stop taking mefloquine, an anti-malaria drug found to cause permanent brain damage in rare cases.
Read article at medicalxpress.com

Lipitor Linked to Musculoskeletal Injuries and Diseases as well as Type 2 Diabetes

September 17, 2013

The cholesterol and blood pressure-regulating statin drug Lipitor has been linked to type 2 diabetes in women. Recently, the drug has also been linked to an increased risk for muscle and joint diseases as well as strains and sprains, according to HealthDay News.
Read article on the Ring of Fire Radio website (USA)

Babies given Calpol just once a month 'are five times as likely to develop asthma'

September 16, 2013

Children who are given Calpol are far more likely to develop asthma, a major study has found. Those given the medicine once a month are five times more at risk while even having it just once a year increases the chances by 70 per cent.
Read article in the Daily Mail (UK)

Church in Wales criticised over its big pharma investments by ethical campaigner

September 15, 2013

The Church in Wales has come under fire for investing millions of pounds in pharmaceutical giants. According to latest accounts, the organisation invested almost £6m into GlaxoSmithKline, more than £5m into Astrazeneca Plc, almost £4.5m into Novartis and more than £3m into Pfizer.
Read article at walesonline.co.uk (Wales, UK)

After GSK, Bayer also targeted in Chinese pharmaceutical probe

September 12, 2013

The German pharmaceutical conglomerate Bayer has become the latest target of an ongoing investigation in China into malpractice in the industry.
Read article in the South China Morning Post

China's Sino Biopharm reels after CCTV accuses unit of bribing doctors

September 12, 2013

The Chinese said they wouldn't ignore home-grown corruption in pharma. Now, that promise is fulfilled. State-owned television network CCTV broadcast bribery allegations against a unit of Sino Biopharmaceutical, saying the company sent doctors on vacations abroad to boost sales of its drugs.
Read article at fiercepharma.com

Some painkillers tied to certain birth defects in study

September 11, 2013

Women taking prescription painkillers such as Oxycontin, Vicodin and Percocet early in pregnancy are twice as likely to give birth to babies with devastating neural tube defects such as spina bifida, a new study suggests.
Read article at medicalxpress.com

Reports of side-effects from Bayer's Xarelto grow: Spiegel

September 8, 2013

Bayer faces a growing number of reports of suspected undesirable side-effects from its stroke prevention pill Xarelto, German magazine Der Spiegel reported, citing data from a federal authority.
Read news report at reuters.com

Exclusive: U.S. prosecutors add China bribe allegations to GSK probe

September 6, 2013

U.S. authorities are investigating British drugmaker GlaxoSmithKline Plc for violations of U.S. anti-bribery laws in China after Chinese government officials accused the company of bribing doctors, three sources familiar with the probe said this week.
Read news report at reuters.com

Comment: With its problems in China mounting fast, and having already paid a record $3 billion in criminal fines in the United States last year, it seems Glaxo may additionally now be heading for yet another brush with the U.S. Justice Department. Notably, therefore, with the Chinese government currently considering whether to fine the company as much as $2 billion, Glaxo is reportedly now considering pulling out of China altogether. Nevertheless, until such time as both governments and patients alike appreciate that the ‘business with disease’ is the largest deception and fraud business in human history, the corrupting influence of the pharmaceutical industry on the practice of medicine will continue to be the single greatest obstacle to the health of mankind.

Judge again blocks Ohio hospital's attempt to force Amish girl to resume cancer treatments

September 4, 2013

A judge has again blocked an Ohio hospital from forcing a 10-year-old Amish girl to resume chemotherapy after her parents decided to stop the treatments. The order siding with the parents comes just a week after an appeals court sent the case back to the judge and told him to give more consideration to the request by Akron Children's Hospital.
Read Associated Press news report on the Fox News website (USA)

Beijing weighing large fines against GlaxoSmithKline
Government accused drugmaker of creating a culture that encouraged widespread bribery

September 4, 2013

The central government is considering whether to slap massive fines on GlaxoSmithKline (GSK), after accusing the drug giant's London headquarters and its former China chief, Mark Reilly, of fostering an aggressive sales culture that indirectly encouraged widespread bribery on the mainland.
Read article in the South China Morning Post

GSK ran hospital bribery programme, say Chinese police

September 3, 2013

Chinese police claim to have found evidence showing GlaxoSmithKline organised a bribery programme targeted at major hospitals at a company level in China, dismissing suggestions that abuses may have been the result of overenthusiastic or rogue sales staff, according to a state media report.
Read article in The Guardian (UK)

Comment: With the news for Glaxo in China getting worse almost by the minute, global awareness of the criminal nature of the pharmaceutical ‘business with disease’ continues to grow. And with Chinese state media now openly stating that the alleged bribery programme was part of Glaxo's officially sanctioned corporate strategy, the company’s public reputation – already critically damaged following the paying of a record $3 billion in criminal fines in the United States last year – has essentially sunk to an all-time low.

Autism Linked to Mothers Taking Antidepressant Drugs

August 31, 2013

Medical researchers at the Johns Hopkins University School of Public Health say the evidence is strong that a pregnant mother who takes certain types of antidepressant drugs will have a dramatically increased risk of her child having autism.
Read article at greenmedinfo.com

Hundreds of Fosamax lawsuits versus Merck ordered readied for trial

August 30, 2013

A federal judge overseeing consolidated litigation against Merck & Co over jaw injuries allegedly caused by the osteoporosis drug Fosamax has ordered hundreds of cases be dispersed to courts across the country for trial. The decision by U.S. District Judge John Keenan in Manhattan marks an unusual and potentially costly development for Merck.
Read news report at reuters.com

Ohio appeals court sides with hospital that wants to force Amish girl to resume chemo

August 28, 2013

An appeals court has sided with a hospital that wants to force a 10-year-old Amish girl to resume chemotherapy after her parents decided to stop the treatments.
Read Associated Press news report on the Fox News website (USA)

Comment: To enforce its “Business with Cancer”, the Drug Cartel has to ensure that nobody, not even a young child, is able to escape its dictatorial grasp. Significantly, therefore, and still unbeknown to millions of people throughout the world, the chemicals used in chemotherapy are toxic and dangerous even after they are excreted through the patient’s skin, urine, stool, tears, semen or vaginal fluids. The people at particular risk include family members, caregivers and literally anyone touching a chemotherapy patient. Even health professionals face health risks while handling chemotherapy drugs. These risks include damage to their DNA, birth defects, the development of cancers and organ damage.

High Doses Of Epilepsy Drug Linked To Birth Defects, Study

August 27, 2013

High doses of a common epilepsy drug leads to an increased risk of having a baby with specific birth defects, according to a new study.
Read article at asianscientist.com (Singapore)

Warfarin a potential heart-attack risk

August 26, 2013

Vitamin K deficiency caused by the long-term use of warfarin has a wider range of health implications than commonly known, including the calcification of organs that can lead to life-threatening problems like heart attack.
Read article at medicalxpress.com

Comment: Given the toxicity of warfarin, the pharmaceutical drug most commonly used when trying to prevent the formation of blood clots in the body, it is significant that it was initially introduced as a poison for killing rats and mice and that it is still used for this purpose. Hardly surprisingly, therefore, warfarin is associated with a long list of serious side effects, including death.

Ohio hospital: Force Amish girl to have chemo

August 23, 2013

An Ohio hospital is fighting to force a 10-year-old Amish girl with leukemia to resume chemotherapy after her parents decided to stop the treatments.
Read article on the Mendocino Beacon website (California/USA)

Comment: Whilst this young girl’s parents had initially permitted her to be subjected to chemotherapy treatment, they subsequently stopped it saying its effects on her were horrible and that they were instead now going to rely on natural approaches such as vitamins. In this respect, we are here reminded of the experiences of young Dominik Feld between 2002 and 2004. Tragically, the fight between an outmoded and inhuman form of treatment – chemotherapy – and a breakthrough treatment with no side effects – the Cellular Medicine approach to cancer – accompanied Dominik to his untimely death. Clearly, therefore, whilst Victory Over Cancer and a Cancer Free World are already now possible, for the time being the people of the world will have to continue to fight to make them a reality.

Arthritis suffers easing pain with paracetomal 'risk heart failure and strokes'

August 17, 2013

Patients who rely on paracetamol to treat their crippling osteoarthritis are at risk of heart failure and strokes, experts have warned.
Read article in the Daily Express (UK)

Comment: A key strategy of the pharmaceutical ‘business with disease’ is the development of drugs that merely mask symptoms while avoiding the curing or elimination of diseases. The use of paracetamol to treat arthritis is a classic example of this. In contrast, Dr. Rath’s Cellular Medicine approach opens up the possibility to prevent and treat this condition naturally, at the cellular level, through the targeted use of specific micronutrients. To read about a clinical study in arthritis conducted by researchers at the Dr. Rath Research Institute, click here. To read about independent studies conducted in arthritis and related joint conditions, visit the online library on the World Health Alphabetization website and the studies worldwide section of our Foundation website.

Micro-Chipped Pharmaceuticals Given Green Light by Medical Totalitarians

August 15, 2013

Proteus Digital Health which recently changed their name from Proteus Biomedical has been given approval by the U.S. Food and Drug Administration to dose you with a micro-chipped pill. The company has been working with the FDA since 2008, at its own admission, to ‘determine the regulatory pathway for this new technology.’
Read article at wakingtimes.com

Comment: Along with the micro-chipped pill, this company has also developed a biometric sensor patch which can send information to a smart phone app. The patch records when a pill is ingested and even keeps track of sleep patterns and physical activity levels. As such, it is conceivably possible that these types of technologies could ultimately be used to try to force patients into taking patented chemical drug medicines by nullifying their medical and/or life insurance if it is discovered they have discontinued them.

Use of ADHD drugs 'increases by 50% in six years'

August 13, 2013

There has been a 50% rise in England in the use of drugs for attention deficit hyperactivity disorder in six years. NHS prescriptions for methylphenidate drugs, including Ritalin, rose from 420,000 in 2007 to 657,000 last year, the Care Quality Commission said.
Read article on the BBC News website (UK)

China investigates France's Sanofi for alleged bribery: Xinhua

August 10, 2013

China has started investigating French drugmaker Sanofi SA for allegedly bribing more than 500 Chinese doctors with about 1.7 million yuan ($277,600) of payments to raise sales, China's Xinhua state news agency said on Saturday.
Read news report at reuters.com

Comment: With a total of 18 GlaxoSmithKline staff in China now being held in relation to alleged bribery and other crimes, and an AstraZeneca executive also detained, it is notable that other companies including Danish drugmaker Novo Nordisk A/S, Eli Lilly & Co and Belgium's UCB SA are similarly now reporting visits from authorities to their offices in China. Nevertheless, positive though this development is, we should not necessarily expect regulatory authorities in other countries to likewise start opening investigations into the criminal nature of the pharmaceutical ‘business with disease’. With previous governmental investigations into the influence of the pharmaceutical industry having essentially been buried in some countries, it would clearly be naïve to expect the political stakeholders of the Drug Cartel to act against their trillion dollar-a-year paymasters.

TV Ads For Statins Lead To Overdiagnosis And Overprescribing: Study

August 5, 2013

Do television ads for cholesterol-lowering pills cause overprescribing? The debate over widespread advertising of prescription medicines is hardly new, but some say the issue remains unresolved. Proponents maintain direct-to-consumer advertising informs people who may not be aware of health risks, while critics argue ads prompt some patients to seek medicines unnecessarily. And statins, of course, have been among the most widely advertised treatments for more than a decade. A new study, however, suggests there is, indeed, an unwanted side effect. Adults who were exposed to such ads were 16 percent to 20 percent more likely to be diagnosed with high cholesterol and 16 percent to 22 percent more likely to be using a statin.
Read article at pharmalive.com

Comment: The entire cholesterol drug business is built on fear – the fear that cholesterol actually causes heart attacks. While this “cholesterol-scare” has become a gold mine for the drug companies – the economic burden of this business is ultimately carried by us, the people. Health professionals, political decision takers and hundreds of millions of patients worldwide have the right to know: What are the proven facts – and what is the fiction promoted by the multi-billion dollar investment business with patented cholesterol-lowering drugs? To learn the truth about the cholesterol myth, visit the cholesterol-fact.org website. To learn how to eradicate high cholesterol levels naturally, visit the Cellular Health section of our Foundation website.

Blood pressure drugs tied to breast cancer risk

August 5, 2013

Women taking a common type of blood pressure drug for a decade or more are over twice as likely to be diagnosed with breast cancer as those not on the medication, a new study suggests.
Read Reuters news report at yahoo.com

BAYER: 150th anniversary on August 1st – Dark Side of Company History ignored

July 31, 2013

Tomorrow the chemical and pharmaceutical company BAYER is celebrating the 150th anniversary of its foundation. In a birthday celebration the German chancellor Angela Merkel described BAYER as an “outstanding advertisement for Germany”. However, none of the commemorative publications is mentioning the numerous crimes the corporation has committed. Instead of acknowledging responsibility for slave labor, poison gas and fatal pharmaceutical products, the dark side of the company's history is completey ignored.
Read press release at cbgnetwork.org (Germany)

Eighteen GSK China staff held as whistleblower allegations emerge

July 27, 2013

GlaxoSmithKline, the British drugs company that is the subject of a major criminal investigation in China, faced similar allegations from an internal whistleblower as early as January, The Sunday Telegraph can reveal.
Read article in the Sunday Telegraph (UK)

Glaxo to pay $229 million to settle Avandia suits with 8 states

July 24, 2013

GlaxoSmithKline has agreed to pay $229 million to settle lawsuits brought by eight U.S. states related to improper marketing of its Avandia diabetes drug, the British drugmaker said on Wednesday.
Read news report at reuters.com

Comment: With its executives in China having recently confessed to "serious" corruption and tax-related offences, and this coming only a year after the company pleaded guilty to criminal charges and paid a record $3 billion in fines in the United States, Glaxo’s problems are clearly showing no sign of going away.

U.S. imports of death-penalty drug ruled illegal

July 23, 2013

A drug used in some U.S. executions, sodium thiopental, can’t be imported into the country because it hasn’t been approved by the U.S. Food and Drug Administration, the U.S. Court of Appeals in Washington ruled in a lawsuit filed by death row inmates.
Read article on the Financial Post website (Canada)

Comment: With the drug industry already having been proven to have supplied the Zyklon B pellets that were used to kill concentration camp prisoners in the gas chambers during WWII, it is high time that not only the companies profiting from selling drugs for use in modern-day executions, but also their stakeholders in government agencies such as the U.S. Food and Drug Administration, are publicly exposed.

Drug companies could be forced to publish secret research to stop them hiding dangerous and unknown side-effects

July 22, 2013

Pharmaceutical companies could be forced to publish secret research into how drugs are created under new European laws, potentially revealing information about dangerous and unknown side-effects.
Read article in the Daily Mail (UK)

AstraZeneca executive detained after Chinese police raid Shanghai HQ

July 23, 2013

Police are investigating AstraZeneca’s work in China and have detained one of the drug maker’s executives, just a week after its rival GlaxoSmithKline first faced allegations of a multimillion-pound bribery scandal.
Read article in The Independent (UK)

Drug Research in China Falls Under a Cloud

July 22, 2013

Executives at the British drug maker GlaxoSmithKline were warned nearly two years ago about critical problems with the way the company conducted research at its drug development center in China, exposing it to potential financial risk and regulatory action, an internal audit found. The confidential document from November 2011, obtained by The New York Times, suggests that Glaxo’s problems may go beyond the sales practices that are currently at the center of a bribery and corruption scandal in China. They may extend to its Shanghai research and development center, which develops neurology drugs for Glaxo.
Read article in the New York Times (USA)

Pharma Enlists Patients To Prevent The Release Of Clinical Trial Data

July 22, 2013

The pharmaceutical industry is quietly working on a concerted, behind-the-scenes effort to prevent the release of clinical trial data, a flashpoint of controversy in recent years over allegations that negative information is being withheld. Trade groups in the US and Europe have so far enlisted patient advocacy groups to discourage regulators from allowing the data to become public, The Guardian reports.
Read article at pharmalive.com

Statins risk for women: Taking cholesterol-lowering drug for more than ten years 'doubles chances of the most common breast cancer'

July 19, 2013

Women who take statins for more than a decade face double the risk of contracting the most common type of breast cancer.
Read article in the Daily Mail (UK)

China Pledges Drug Sector Crackdown Amid Glaxo Bribes Probe

July 17, 2013

China’s food and drugs regulator pledged to crack down on illegal activities in the nation’s pharmaceutical industry after a GlaxoSmithKline Plc (GSK) executive described on national television how he used bribes to boost the company’s sales.
Read article at bloomberg.com

Danish Doc Charged With Fraud For Payments From Drugmakers

July 15, 2013

Now, let us turn our attention from the bribery scandal in China involving GlaxoSmithKline to Norway, where a cardiologist affiliated with a major hospital has been charged with fraud after buying furniture and going on fishing trips with money from Merck and Pfizer, which made payments for clinical trial work that was supposed to have been sent directly into hospital accounts, Jyllands-Posten reports.
Read article at pharmalive.com

IMS Study Forecasts Rebound in Global Spending on Medicines, Reaching Nearly $1.2 Trillion By 2016

July 12, 2013

Following several years of slowing growth, the global market for medicines is poised to rebound from an expected low point of 3-4 percent growth in 2012 to 5-7 percent in 2016, according to a new forecast issued by the IMS Institute for Healthcare Informatics. The report, The Global Use of Medicines: Outlook through 2016, found that annual global spending on medicines will rise from $956 billion in 2011 to nearly $1.2 trillion in 2016, representing a compound annual growth rate of 3-6 percent.
Read press release at imshealth.com

Comment: With total annual global drug sales for the Pharma Cartel now forecast to reach nearly 1.2 TRILLION dollars by 2016, it is worth remembering this the next time someone asks you to donate money to a charity supporting research into new drug treatments for cancer and other chronic diseases. After all, with astronomical sales figures like these, the fraudulent pharmaceutical "business with disease" is clearly not in need of charitable donations to fund its toxic drug research.

Our medical schools must not become shills for big pharma

July 12, 2013

Most Canadians might be surprised to learn that medical students in Canada are routinely taught by faculty who have financial ties, and work in partnership, with drug companies.
Read article on The Globe and Mail website (Canada)

Data in Novartis drug study manipulated
Kyoto university sounds alarm on researcher's claims about hit blood pressure medicine Diovan

July 12, 2013

The data used in a clinical study on Novartis Pharma K.K.’s blockbuster blood pressure drug Diovan were manipulated, Kyoto Prefectural University of Medicine has revealed.
Read article on The Japan Times website

China says GSK executives have confessed to bribing doctors
UK drugs maker GlaxoSmithKline under fire after executives in China confess to 'serious economic crimes' to boost revenue

July 11, 2013

Executives working for the UK drug maker GlaxoSmithKline in China have confessed to "serious" corruption and tax-related offences, China's security ministry said on Thursday, amid a wide-ranging series of investigations into foreign firms operating in the country.
Read article in The Guardian (UK)

Comment: Glaxo stands accused of dispensing some 3 billion yuan (£323m) in bribes in China since 2007, with police saying they have uncovered more than 700 middlemen through which the company allegedly funneled money to health officials and doctors in order to prescribe its drugs. Seemingly, therefore, despite the record $3 billion in fines Glaxo paid in the US last year for criminal behavior, its global business model would appear to have remained unaltered.

A Bayer Drug, The EMA And Transparency... Or The Lack Thereof

July 11, 2013

In yet another instance in which transparency involving pharmaceuticals has been questioned, the head of the Swedish organization that assesses health care products has criticized the European Medicines Agency for its closed-mouth approach to allowing physicians to resume use of a controversial Bayer drug that had been suspended several years ago. In a letter published in The Lancet, Mans Rosen complains the EMA refused to make available the scientific information that was the basis for its recommendation last year to lift a suspension for Trasylol, which is used to control bleeding during heart surgery.
Read article at pharmalive.com

Acid reflux drugs may lead to heart disease, says Houston study

July 10, 2013

Drugs that millions of people take for acid reflux may contribute to heart disease, according to a Houston study, the latest to raise concerns about possible harmful effects from long-term use of the common treatment.
Read article on the Houston Chronicle website (USA)

Late effects of childhood cancer treatments haunt survivors

July 9, 2013

Fifteen years ago, when she was a child and suffering from a brain tumour that if left unchecked would have killed her, Danielle Vacheresse received heavy doses of radiation in hopes the tumour would be killed instead. At the time, nothing was said to her parents about what the future might hold, or what the “late effects” of radiation might be.
Read article on the Vancouver Sun website (Canada)

Comment: To learn about a natural health research breakthrough that promises to turn cancer from being an almost certain 'death verdict' into a manageable disease, read the groundbreaking book, ‘Victory Over Cancer,’ by Dr. Rath and Dr. Aleksandra Niedzwiecki. With the publication of this book, the ‘Age of intoxication’ by radiation and chemotherapy is being replaced by the ‘Age of cellular regulation’.

India's poor 'duped' into clinical drug trials

July 7, 2013

Niranjan Lal Pathak couldn't believe his luck initially. When a doctor at a hospital in central India offered the factory watchman free treatment for a heart complaint, he jumped at the chance. It was five years ago and the family of the 72-year-old says he didn't realise that the Maharaja Yashwantrao Hospital in the city of Indore was about to enroll him in a trial of an untested drug.
Read article at medicalxpress.com

Diagnosis: Insufficient Outrage

July 4, 2013

Recent revelations should lead those of us involved in America’s health care system to ask a hard question about our business: At what point does it become a crime?
Read article by Professor H. Gilbert Welch in the New York Times (USA)

Painkiller overdoses deaths rise sharply among U.S. women: study

July 3, 2013

Deaths from prescription painkiller overdose among women in the United States have risen sharply in recent years, said a report released Tuesday by the U.S. Centers for Disease Control and Prevention (CDC). Between 1999 and 2010, the death toll from painkiller overdose increased more than 400 percent among U.S. women, compared to 265 percent in U.S. men, the report said. A total of 48,000 U.S. women died from these drugs during that period, it said.
Read article at xinhuanet.com (China)

New oral anticoagulants may increase GI bleeding risk

July 2, 2013

Recipients of new oral anticoagulants, including dabigatran and rivaroxaban, may be more likely to experience gastrointestinal bleeding, according to a recent study.
Read article at healio.com (USA)

Woman who was left blind and disfigured by prescription drug loses fight for $21m payout

June 29, 2013

A woman who was left burned and blinded, nine years after taking a prescription drug, has lost her legal fight for compensation. Karen Bartlett took a drug to ease shoulder pain back in 2004, but this week the Supreme Court ruled that Mutual Pharmaceutical Co., the maker of the drug should not be held responsible for her injuries because the company had made the brand drug's formula and warning label.
Read article in the Daily Mail (UK)

Comment: As the New York Times has pointed out, as a result of this damaging US Supreme Court decision, Americans who are grievously harmed by generic drugs in future may find it virtually impossible to win compensation for their injuries. Without any doubt, therefore, this decision benefits the interests of the pharmaceutical “business with disease” – and profit is once again being placed before life.

India bans three drugs including anti-diabetes Pioglitazone and painkiller Analgin

June 27, 2013

NEW DELHI – In order to provide non-hazardous drugs to patients in the country, the Indian government has banned sale of three drugs – painkiller Analgin, anti-diabetes drug Pioglitazone and anti-depressant deanxit. “The government has banned three popular medicines—pioglitazone, painkiller analgin and anti-depressant deanxit—in the wake of health risks associated with them,” India’s leading newspaper, Times of India reported.
Read article at nationalturk.com (Turkey)

Truth in Pharmaceutical Advertising

June 27, 2013

Advertising is a powerful and effective tool for promoting the sale of products, especially from the drug and food industries, due to their huge profits. Awareness of a need for government to keep advertisers in line goes back to the end of the 19th century. The very first US Pure Food and Drug Act was passed in 1906, when Theodore Roosevelt was president. Currently, the Federal Trade Commission requires that advertising must be "truthful and non-deceptive." Advertisers must have evidence to back up their claims. Advertisements cannot be "unfair," and must inform about anything that may "materially affect" the consumer's decision. However, those terms are not easily defined. And corporations redefine them for their own benefit.
Read news release at orthomolecular.org

Nearly 70% of Americans "taking at least one Rx drug"

June 25, 2013

Almost 70% of Americans are taking at least one prescription drug, more than half take two, and 20% are on five or more, according to new research.
Read article at pharmatimes.com

Comment: These statistics provide a shocking illustration of the extent to which decades of promoting and expanding diseases has dramatically increased the market of the pharmaceutical investment industry in the United States. Unbeknown to millions of patients worldwide, the pharmaceutical “business with disease” is the largest deception and fraud business in human history. With the eradication of diseases by its very nature being incompatible with, and diametrically opposed to, the interests of the Pharma Cartel, the patented synthetic chemicals produced by drug companies frequently cause side effects and further diseases – thus resulting in patients being prescribed additional drugs to “treat” them. This problem, known as ‘polypharmacy,’ is particularly common in elderly patients.

Antidepressants 'could be risk to unborn babies'

June 24, 2013

The risk posed by some popular antidepressants in early pregnancy is not worth taking for women with mild to moderate depression, an expert has warned. Professor Stephen Pilling says evidence suggests SSRIs can double the risk of a child being born with a heart defect. The drugs have been used by up to one in six women of child-bearing age.
Read article on the BBC News website (UK)

Supreme Court justices block generic drug liability lawsuits

June 24, 2013

The U.S. Supreme Court ruled on Monday that generic drugmakers cannot be sued under state law for adverse reactions to their products, a decision that consumer advocates called a blow to patient safety.
Read news report at reuters.com

Profiting From Pain

June 22, 2013

Narcotic painkillers are now the most widely prescribed class of medications in the United States, and prescriptions for the strongest opioids, including OxyContin, have increased nearly fourfold over the past decade. There is increasing evidence, however, that such drugs, along with being widely abused, are often ineffective in treating long-term pain and can have serious consequences, particularly when used in high doses.
Read article in the New York Times (USA)

Pfizer settles with patients who had suicidal behaviour

June 19, 2013

Drug maker Pfizer will pay $4.8 million in compensation to Canadians who tried to commit suicide after being prescribed a drug to treat seizures.
Read article in the Toronto Sun (Canada)

Supreme Court Rules Human Genes Cannot Be Patented, But...

June 13, 2013

In a unanimous decision with important implications for biomedical research, the US Supreme Court has invalidated key parts of two patents held by Myriad Genetics that form the basis of a widely used genetic test for breast and ovarian cancers. But the court also drew a distinction between the right to patent genes based on naturally occurring DNA and genetic material created synthetically in laboratories.
Read article at pharmalive.com

Comment: As this article points out, the US Patent & Trademark Office has already granted patents on some 4,000 human genes. To what extent these may now be challenged in the US court system is currently unclear. Nevertheless, by ruling against Myriad Genetics and deciding that human genes cannot be patented, the US Supreme Court has clearly taken an important step in the right direction.

Yaz and Yasmin birth control pills linked to 23 deaths

June 11, 2013

Health Canada says it has received reports of at least 23 young Canadian women who have died while taking one of two commonly prescribed birth control pills, Yaz and Yasmin.
Read article at montreal.ctvnews.ca (Canada)

Diabetes drug linked to cancer of the pancreas

June 10, 2013

Medical experts are reviewing the safety of a widely used drug to treat diabetes after experts linked it to pancreatic cancer. Researchers have suggested that there could be a link between incretin mimetics, which are used to treat type 2 diabetes by regulating blood sugar, and the disease.
Read article in the Yorkshire Post (UK)

MRI detects early damage to chemotherapy child hearts

June 10, 2013

Detecting early damage to a child's heart following chemotherapy is possible using MRI scans, says a study from Canada. Even when children's heart function appeared to be normal, a new MRI method of mapping the heart was able to identify damage, University of Alberta researchers said.
Read article on the BBC News website (UK)

Comment: Chemotherapy drug treatments for cancer are extremely toxic, with many of them actually being known to cause new cancers. Amongst these substances are some of the most toxic chemicals known to man. The first chemotherapy drug was derived from 'mustard gas', a chemical warfare agent used in World War I as a weapon, with drug derivatives of this deadly gas still being used in cancer patients today as mechlorethamine, cyclophosphamide, chlorambucil and ifosfamide. To learn about a scientific research breakthrough that promises to turn cancer from being an almost certain 'death verdict' into a manageable disease, click here.

Bill Gates, Big Pharma, Bogus Philanthropy

June 7, 2013

Many people admire Bill Gates for his intelligence, entrepreneurial spirit and, most recently, his philanthropy. That is all well and good, but we mustn’t forget that he is a relentless capitalist who, throughout his life, dedicated his efforts to only one purpose: making a ridiculous sum of money. Let us also not forget that corporations are, by law, required to do everything possible to maximize their profits and therefore, every single action they take should be viewed as a money-making scheme. Sometimes this means repairing or improving their image through seemingly charitable actions that are designed to allow them, in the long term, to exploit more people without scrutiny or resistance.
Read article at newsjunkiepost.com (USA)

Comment: This article describes how the Bill & Melinda Gates Foundation is effectively a huge tax-avoidance scheme for super-wealthy individuals and companies who have made billions from exploiting the world’s people. As a 2007 investigation by the Los Angeles Times similarly showed, the Gates Foundation’s investments have included stockholdings in multi-billion dollar drug companies and other corporations that have been criticized for worsening poverty, heavy pollution and other unethical practices. In this respect, it essentially copies a model originally designed by John D. Rockefeller a century ago. By investing in the very companies in which Gates owns millions in stocks, financial returns are guaranteed through sales and intellectual-property rights. Significantly, therefore, an analysis published in 2011 showed how several members of the Gates Foundation’s management committee, leadership teams, affiliates and major funders are currently or were previously members of the boards or executive branches of major drugmakers, including Merck and Novartis. As such, with a close examination of its network revealing a wide variety of links to billionaires, multinational corporations, governments, international organizations and others, and its investments in the pharma cartel still ongoing, it is high time that Gates was held to account for his actions instead of being allowed to “whitewash” them through what is increasingly becoming known as “philanthrocapitalism.”

Statins could lead to muscular injuries, scientists warn

June 4, 2013

Millions of people taking statins to lower their cholesterol could be putting themselves at risk of muscular injuries, researchers have warned.
Read article in The Daily Telegraph (UK)

Risk of kidney disease doubled with use of fluoroquinolone antibiotics

June 3, 2013

The risk of acute kidney disease is doubled for people taking oral fluoroquinolone antibiotics, according to a study of published in CMAJ (Canadian Medical Association Journal).
Read article at medicalxpress.com

High doses of common painkillers increase heart attack risks

May 29, 2013

Long-term high-dose use of painkillers such as ibuprofen or diclofenac is "equally hazardous" in terms of heart attack risk as use of the drug Vioxx, which was withdrawn due to its potential dangers, researchers said on Thursday.
Read news report at reuters.com

Comment: The uncomfortable reality facing government health policy makers today is that there are unsolvable conflicts of interest between private enterprise and public health. Moreover, with a recent survey of 4,000 people from six countries finding that 60% of respondents believe the drug industry is more interested in treating cancer than curing it, it would appear that the majority of patients already understand this. As such, with the dangers of painkillers such as ibuprofen or diclofenac now being found to be comparable to those of Vioxx, and an estimated 27,000–60,000 patients having died while taking Vioxx between 2000 and 2004, it clearly unacceptable that the people of the world are being kept in ignorance about their health and treated with toxic, life-threatening drugs that merely mask symptoms. To learn about the main principles governing the pharmaceutical “business with disease, click here.

Physicians insufficiently informed of the side effects of drugs

May 29, 2013

An international study involving 255 physicians practicing in Vancouver, Montreal, Sacramento and Toulouse found that physicians are not given enough information about the adverse effects of drugs during presentations made by medical sales representatives from pharmaceutical companies.
Read article at medicalxpress.com

Germans Find New Evidence of Shady Soviet-Era Drug Trials

May 24, 2013

Germany’s Der Spiegel recently published a string of articles indicating that, until the fall of the Berlin Wall, major pharmaceutical companies conducted hundreds of drug trials in East Germany. In all, the reports suggest, more than 50,000 East German patients served as guinea pigs—many without their knowledge or consent.
Read article at businessweek.com

Diabetes warning over use of statins: People who take the drugs are at increased risk of developing condition

May 23, 2013

People taking statins face an increased risk of developing diabetes, warn researchers. They found a 10 per cent extra risk linked to taking simvastatin – the most commonly prescribed anti-cholesterol drug – which rose to 22 per cent for those taking atorvastatin.
Read article in the Daily Mail (UK)

Medicine, mutilation or stock manipulation? The strange case of Angelina Jolie

May 22, 2013

Depending on where you look, Angelina Jolie’s decision to have a double mastectomy as a protective measure against breast cancer is being described as incredibly brave, amazingly ill-informed or unbelievably greedy and manipulative.
Read article on the Alliance for Natural Health (Europe) website

Let’s Fight Big Pharma’s Crusade to Turn Eccentricity Into Illness

May 17, 2013

Nature takes the long view, mankind the short. Nature picks diversity; we pick standardization. We are homogenizing our crops and homogenizing our people. And Big Pharma seems intent on pursuing a parallel attempt to create its own brand of human monoculture. With an assist from an overly ambitious psychiatry, all human difference is being transmuted into chemical imbalance meant to be treated with a handy pill.
Read article at wired.com

Drug companies blast county's pill disposal plan

May 16, 2013

SEATTLE -- A lawyer representing the pharmaceutical industry threatened to sue King County if officials move forward with a proposed prescription drug disposal plan. Pharmaceutical Research and Manufacturers of America (PhRMA) legal counsel Marjorie Powell delivered that warning to the King County Board of Health this afternoon in a public hearing on a proposed drug return system which would require drug manufacturers to pay for the collection and disposal of unwanted medications.
Read article at komonews.com (USA)

Drugs giants used Communist East Germany for 'illegal' trials

May 12, 2013

Leading Western pharmaceutical companies paid millions of pounds to former Communist East Germany to use more that 50,000 patients in state-run hospitals as unwitting guinea pigs for drug tests in which several people died, it was revealed today.
Read article in the Independent on Sunday (UK)

Victims group alleges thalidomide still distributed in Spain after withdrawal by manufacturer

May 8, 2013

MADRID - Spanish victims of thalidomide on Wednesday published documents they claim proves a German drug company kept distributing the notorious drug in Spain six months after it was taken off the market in other countries.
Read article on the Windsor Star website (Canada)

Hospital bug Clostridium difficile linked to the use of Prozac

May 7, 2013

Taking the antidepressant Prozac increases the risk of infection by a hospital bug, a study has shown.
Read article on the Belfast Telegraph website (Northern Ireland)

US FDA warns pregnant women to not use valproate migraine prevention medicines

May 7, 2013

The US Food and Drug Administration is alerting health care providers and patients that medications including and related to valproate sodium, an epilepsy treatment, can cause decreased IQ scores in children whose mothers took the drugs during pregnancy.
Read article at thepharmaletter.com

Docs Down Under Agree To Greater Disclosure Of Pharma Ties

May 1, 2013

In a move toward acknowledging a need for greater transparency, the Australian Medical Association has endorsed increased disclosure of the financial relationships between physicians and the pharmaceutical industry. The move came as a bill is being debated in Parliament that emulates the requirements found in the Sunshine provision of the Affordable Care Act that goes into effect this year in the US.
Read article at pharmalive.com

Jury awards plaintiff $6.5 mln in first Takeda Actos trial

April 30, 2013

A California jury has awarded $6.5 million to a man who accused the Japanese drugmaker Takeda Pharmaceutics of failing to provide an adequate warning that its diabetes drug Actos could cause bladder cancer. The case in Los Angeles Superior Court is one of over 3,000 lawsuits pending in courts across the country over the medication and was the first to go to trial and reach a verdict.
Read article at thomsonreuters.com

Epilepsy Drug Used During Pregnancy Increases Baby’s Autism Risk

April 24, 2013

Children born to mothers who took the anti-seizure drug valproate were five times more likely to be born with autism than those whose mothers didn’t take the medication, a Danish study found. The epilepsy drug was also tied to a three-fold increase of autism spectrum disorder, which includes Asperger syndrome and other developmental disorders, according to research published yesterday in the Journal of the American Medical Association.
Read article at businessweek.com

Ingredient in Biogen's Tecfidera MS Drug Linked to Brain Infection

April 24, 2013

A major medical journal published two case reports detailing incidences of a rare brain infection in patients taking a therapy that included the active ingredient found in Biogen Idec Inc.'s multiple sclerosis drug, Tecfidera.
Read article at foxbusiness.com (USA)

Another Link Between Autism And Antidepressants?

April 23, 2013

For the second time in two years, a study has suggested that there may be a connection, albeit a tentative one, between autism and the use of antidepressants by pregnant moms.
Read article at pharmalive.com

Settlement over Vioxx under fire

April 19, 2013

Drug company Merck has reached a $540,000 settlement with Australians who claim rofecoxib (Vioxx) gave them heart problems, but a judge is questioning if the deal is fair.
Read article on the Rheumatology Update website (Australia)

Troubling New Signals? Diabetes Drugs & Adverse Event Reports

April 18, 2013

For the past two months, there has been rising controversy over the extent to which certain diabetes drugs called GLP-1 inhibitors may cause pancreatitis and pancreatic cancer. Although links to pancreatitis are actually not new, one of two recent papers suggested pre-cancerous cell growth may be cause for concern, prompting both the FDA and the European Medicines Agency to start investigations.
Read article at pharmalive.com

Takeda’s Actos Diabetes Drug Tied to Cancer, Jury Is Told

April 16, 2013

Takeda Pharmaceutical Co. (4502), Asia’s biggest drugmaker, hid the cancer risks of its Actos drug to protect billions in sales, a jury was told in the first of more than 3,000 lawsuits over the diabetes medication to go to trial.
Read article at bloomberg.com

Ghost In The Attic: Most Medical Journals Lack Ghostwriting Policies

April 11, 2013

For the past few years, the controversy over ghostwriting has festered, creating embarrassing moments for medical journals and, at times, damaging revelations for drugmakers due to instances of undisclosed data. But despite numerous attempts to address the issue and improve transparency, a new study finds that most medical journals have failed to take explicit steps to formulate a policy.
Read article at pharmalive.com

Doctors Not Informed of Harmful Effects of Medicines During Sales Visits

April 10, 2013

The majority of family doctors receive little or no information about harmful effects of medicines when visited by drug company representatives, according to an international study involving Canadian, U.S. and French physicians.
Read article at sciencedaily.com

The Pharma Reputation In the US And UK Is... Not So Good

April 8, 2013

Earlier this year, a survey of 600 patient groups around the world found that the overall reputation of the pharmaceutical industry - or more specifically, 29 large drugmakers - had taken a nose dive.
Read article at pharmalive.com

UK medical professionals paid £40m last year by drug companies

April 5, 2013

UK-based doctors, nurses and other healthcare professionals were given £40 million by big pharmaceutical companies in just one year, figures suggest.
Read article in the Daily Telegraph (UK)

H2O dear: The rising problem of drugs in our water supplies

April 3, 2013

Fancy some diclofenac in your water?  No?  How about some nice 17-beta-oestradiol instead?  If you live in the European Union (EU), you may well be drinking these and other substances already – and nothing much is being done about it.  And if you’re not already familiar with these drugs, you might like to know that diclofenac is a popular non-steroidal anti-inflammatory drug (NSAID) and that the oestradiol in our drinking water originates mainly from contraceptive pills and hormone replacement therapy (HRT).
Read article on the Alliance for Natural Health website (Europe)

All glucocorticoids linked to increased risk of VTE

April 1, 2013

Use of all glucocorticoids is associated with a two- to threefold increased risk of venous thromboembolism, depending on the type of glucocorticoid, the route of administration, and other factors, according to a report published online April 1 in JAMA Internal Medicine.
Read article at clinicalendocrinologynews.com (USA)

French Regulator Investigated Over Servier Scandal

March 22, 2013

The scandal over a Servier Laboratories diabetes pill, which has been blamed for at least 500 deaths in France, has now ensnared the French regulatory agency. The ANSM has come under formal investigation for alleged involuntary manslaughter over concerns the agency neglected to respond to numerous reports that the Mediator drug, which was withdrawn four years ago, was causing serious harm.
Read article at pharmalot.com

Comment: Despite warnings dating back as early as 1998, successive French health ministers ignored scientific advice that Mediator was at best useless, and at worst highly dangerous. Notably, therefore, former French President Nicolas Sarkozy – who, in 2004, coerced the marriage between French pharmaceutical dwarf Sanofi and Swiss/German drug giant Aventis/Hoechst – previously worked for Servier as a lawyer. With some estimates suggesting that the drug may possibly have killed up to 2,000 people, serious questions as to how it was officially approved, and subsidized for 33 years by the French health service, remain unanswered.

BAYER: Company History Whitewashed

March 21, 2013

BAYER is staging costly celebrations to mark its 150th birthday, yet the company´s numerous crimes are not mentioned at all in the commemorative publications. Instead of acknowledging responsibility for forced labor, poison gas and fatal pharmaceutical products, the company's history is wholly ignored.
Read press release at cbgnetwork.org (Germany)

Comment: World War II – a war that cost the lives of more than 60 million people – was planned and financed by IG Farben, the world’s largest chemical/pharmaceutical cartel at that time. Consisting of Bayer, BASF, Hoechst and other companies, IG Farben companies financed the rise to power of the Nazi party and the transformation of German democracy into a dictatorship. After WWII, the corporate executives of Bayer and IG Farben were tried at the Nuremberg War Crimes Tribunal and found guilty of plunder, exploitation, slavery and mass murder. In particular, it was found that criminal medical experiments had been conducted by Bayer and IG Farben on the enslaved inmates of Auschwitz and other concentration camps in order to test the effects of deadly gases and vaccines. Drugs forcibly given to the inmates were used to develop the first generation of chemotherapy drugs. Some of the most heinous crimes were conducted by Fritz ter Meer, a director of Farben who had been responsible for the construction and operation of IG Auschwitz, a 100% subsidiary of IG Farben that was the largest industrial complex in the world at that time. Concentration camp prisoners who were too weak or too sick to work were selected at the main gate of the IG Auschwitz factory and sent to the gas chambers. Even the chemical gas Zyklon B used for the annihilation of millions of people was derived from the drawing boards and factories of IG Farben. Nevertheless, despite ter Meer's appalling crimes, he was released from prison after serving only two years. Then, in 1956, fully aware that he was a convicted war criminal, Bayer appointed him as chairman of its supervisory board, a post he went on to hold for 8 years. Subsequently, after ter Meer’s death in 1967, the company reportedly continued to lay wreaths on his grave until at least 2006. To learn more about the hidden history of Bayer and IG Farben, visit the Profit Over Life website.

High-dose statins 'raise risk of serious kidney problems'

March 20, 2013

High-dose statins taken by millions of people are putting them at increased risk of potentially fatal kidney problems, researchers are warning.
Read article in the Daily Telegraph (UK)

Comment: Cholesterol-lowering drugs are now one of the largest earning sectors of the pharmaceutical investment business. Notably, therefore, a key fact that the drug industry is not telling you about cholesterol is that it is essential for life. As the structural constituent of the wall of billions of cells in our body, it is the precursor of many biological molecules including hormones (e.g. estrogen and testosterone). Moreover, there exists no scientific evidence that cholesterol, even in moderately elevated concentrations, damages the blood vessel walls and causes atherosclerotic plaques and heart attacks if the blood vessel walls are structurally intact. For cholesterol to have a damaging effect on otherwise intact blood vessel walls in test animals (i.e. to cause plaques) it must be artificially increased to levels essentially never observed in humans. In summary, there is no scientific evidence that cholesterol – even at moderately elevated levels – can damage an otherwise intact blood vessel wall. To learn more, visit the Cholesterol Facts website.

First Chinese pharma firm fined for price fixing in the US

March 18, 2013

A US court has fined North China Pharmaceutical Co (NCPC) $162 million for price fixing, the first time a Chinese drug company to be fined in an US antitrust case. Two other Chinese ''Vitamin C'' manufacturers, Weisheng Pharmaceutical Co Ltd and China Pharmaceutical, who were also named in the lawsuit, had last week settled the case out of court by offering to pay an agreed $22.5 million.
Read article at domain-b.com

Comment: Pharmaceutical companies have a long history of colluding to fix prices for vitamins. In 1999, following a class-action case in the United States, seven of the world's largest drug companies paid more than $1.1 billion to settle a lawsuit that sought damages as a result of a criminal scheme to fix prices. Subsequent to the US lawsuit, the cartel was also subject to successful court actions in Canada, Europe and Australia. Thus, while refusing to promote the medical breakthroughs of Cellular Medicine, multinational drug companies conspired to take advantage of them by engaging in criminal price-fixing on a global level. The fraudulent profits these companies made from their criminal practices may have reached hundreds of billions of dollars. Compared to that, the fines these companies had to pay were insignificant. To learn more, read chapter 11 of Dr. Rath’s classic book, “Why Animals Don’t Get Heart Attacks – But People Do!

Teva Pays $2.3 Million For Pollution Violations

March 15, 2013

As increasing concern mounts over the extent to which pharmaceuticals may harm the water supply, drugmakers are being scrutinized quite closely for infractions that contribute to the problem. The latest instance involves Teva Pharmaceuticals, which agreed to pay $2.3 million to resolve a series of violations at a Missouri plant where antibiotics are made.
Read article at pharmalot.com

'Chemical cosh' drugs given to the elderly triple the risk of stroke

March 13, 2013

Antipsychotic drugs given to the elderly could triple the risk of potentially fatal strokes, The Alzheimer’s Society claims. The charity also suggests that the medication could double the risk of death and leave patients unable to walk or talk.
Read article in the Daily Mail (UK)

Popular antibiotic Zithromax may cause heart rhythm problems, warns U.S. drug regulator

March 13, 2013

A popular antibiotic used to treat a variety of infections may cause a potentially fatal heart rhythm problem in some patients. Azithromycin, also known under its brand name Zithromax, is prescribed for infections of the ears, lungs, sinuses, skin, throat and reproductive organs.
Read article in the Daily Mail (UK)

Merck Hid Fosamax’s Bone-Weakening Risks, Lawyer Contends

March 12, 2013

Merck & Co. officials hid the risks that its Fosamax osteoporosis drug could weaken bones and lead to femur fractures, a lawyer told a New Jersey jury in the first case raising such claims to come to trial.
Read article at bloomberg.com

Trial Deaths, But Little Compensation In India

March 12, 2013

As India attempts to craft new rules for governing clinical trials, another report focuses attention on an underlying problem plaguing both regulators and the pharmaceutical industry – the number of patient deaths attributed to trials and the contentious issue of compensation by drugmakers.
Read article at pharmalot.com

Anemia Drug Does Not Improve Health of Anemic Heart Failure Patients, Study Shows

March 10, 2013

Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients -darbepoetin alfa -- does not improve patients' health, nor does it reduce their risk of death from heart failure.
Read article at sciencedaily.com

Internet Search Data Finds Unreported Side Effects

March 7, 2013

Here is a finding that will likely unnerve drugmakers. A team of researchers used search tools to review queries made by six million people over a 12-month period and were able to identify evidence of unreported side effects that were caused by interactions between drugs before they were detected by the FDA. Specifically, the researchers used automated software to identify searches for info on the Paxil antidepressant, the Pravachol cholesterol drug or both pills during 2010. And they found evidence that the combination of these drugs caused high blood sugar. The study was published in the Journal of the American Medical Informatics Association.
Read article at pharmalot.com

Report shows trace amounts of pharmaceutical drugs turning up in water supply

March 6, 2013

LONG ISLAND, N.Y. — A report that recently came out showed that trace amounts of pharmaceutical drugs are showing up in the water supply in Long Island, N.Y., according to Long Island News.
Read article at watertechonline.com (USA)

Comment: Evidence is growing worldwide that the pharmaceutical industry is polluting the environment and that drinking water supplies are now contaminated with measurable amounts of dangerous synthetic chemical drugs. A study published in 2009, for example, found that fish caught near wastewater treatment plants serving five major U.S. cities had residues of pharmaceuticals in them. Testing has revealed that at least 46 million Americans are drinking water contaminated with pharmaceuticals. Meanwhile, scientists in the UK have found cancer drugs in tap water and rising levels of antidepressant drugs in coastal waters which they fear could seriously upset the natural balance of the ecosystem and potentially damage the food-chain. The world’s highest drug levels in water are believed to occur in India, where 21 different active pharmaceutical ingredients – at 150 times the highest levels detected in the U.S. – have been found.

Takeda Put Actos Sales Ahead of User Safety, Witness Says

March 6, 2013

Takeda Pharmaceutical Co., Asia’s biggest drugmaker, put sales of its Actos diabetes drug ahead of concerns about consumer safety, a witness testified in the first trial over claims the medicine caused cancer.
Read article at bloomberg.com

The Pharma Influence On Budding Medical Trainees

February 28, 2013

Despite various campaigns to strengthen conflict-of-interest policies at medical schools and academic medical centers, a new survey finds that medical students and residents continue to receive meals, various gifts and educational materials from pharmaceutical industry sales reps. As a result, the study authors say existing efforts are making a difference, but still do not go far enough.
Read article at pharmalot.com

The drug that's harmed more children than Thalidomide

February 26, 2013

Epilim, one of the registered trade names for sodium valproate which controls electrical activity in the brain to halt seizures, is now being blamed for a medical disaster worse than the Thalidomide scandal of the Sixties — when around 2,000 babies were tragically born with missing or shortened limbs after their mothers took the drug Thalidomide to control morning sickness.
Read article in the Daily Mail (UK)

Glaxo DMD Drug Tied to Serious Side Effects, Hospitalizations

February 25, 2013

Duchenne muscular dystrophy patients treated with GlaxoSmithKline's experimental drug drisapersen have been hospitalized due to kidney toxicity and low platelet counts, according to a Glaxo scientist who spoke at a research meeting in Rome last Sunday.
Read article at thestreet.com

Merck, Bristol Diabetes Drugs Linked to Pancreatitis Risk

February 25, 2013

Diabetes drugs sold by Merck & Co. and Bristol-Myers Squibb Co. may double a user’s risk of developing an inflammation of the pancreas linked to cancer and kidney failure, an analysis of insurance records shows.
Read article at bloomberg.com

Italy Probes Roche & Novartis For Forming A ‘Cartel’

February 20, 2013

The latest chapter in the controversy over the use of over two Roche drugs for treating wet macular degeneration – Avastin and Lucentis – is being written in Italy, where antitrust regulators opened a probe into whether the drugmaker and Novartis, which markets one of the medicines in Europe, formed a cartel.
Read article at pharmalot.com

Fatal drug overdoses in U.S. increase for 11th consecutive year

February 19, 2013

Fatal drug overdoses have increased for the 11th consecutive year in the United States, new data show. According to a research letter published Tuesday from the National Center for Health Statistics, 38,329 people died of drug overdoses in the United States in 2010, an uptick from the previous year and the latest sign of a deadly trend involving prescription painkillers.
Read article in the Los Angeles Times (USA)

Comment: In the world of the ‘business with disease’, the key driving forces are profit and the accumulation of wealth. It isn’t important to the Drug Cartel how these profits are generated, simply that they are. To learn more about the main principles governing the pharmaceutical industry, click here.

Takeda Faces First Trial Over Actos Diabetes Drug in L.A.

February 19, 2013

Takeda Pharmaceutical Co., Asia’s biggest drugmaker, is facing its first trial of lawsuits alleging that its Actos diabetes drug caused cancer in some patients. Jack Cooper, a former cable splicer for Pacific Bell who took Actos for more than two years, contends officials of Takeda’s U.S. unit didn’t properly warn consumers that Actos could cause bladder cancer.
Read article at bloomberg.com

Merck Pays $688M To Settle Suits Over Enhance Trial

February 14, 2013

On the eve of a widely anticipated courtroom battle, Merck has agreed to settle shareholder lawsuits over the highly controversial Enhance clinical trial for the Vytorin cholesterol pill. The latest deal actually resolves two separate lawsuits in which the drugmaker has agreed to make a total payment of $688 million, which was described as one of the 25 largest securities class action settlements ever by the lawyers who represented Merck shareholders.
Read article at pharmalot.com

Commonly used painkiller 'should be banned over heart risk'

February 12, 2013

A painkiller used by at least a million people in Britain a year should be banned because it raises the risk of heart attack and stroke by almost half, say British academics.
Read article in the Daily Telegraph (UK)

Safety review for popular contraceptive pill

February 5, 2013

Australian health authorities are reviewing the safety of a popular contraceptive pill sold under the brand name Diane. The Therapeutic Goods Administration (TGA) said it would monitor the safety of drug after the French medicines agency suspended its marketing authorisation.
Read news report at yahoo.com

Survey shock for pharma

February 4, 2013

A survey released to tie in with today’s World Cancer Day finds that most people feel pharma companies see cancers as a making-money opportunity rather than as a blight to eradicate.
Read article at pharmafile.com

Comment: The only reason that cancer still remains a death verdict is the billions of dollars drug companies make from selling chemotherapy drugs. As such, this survey provides clear evidence that the people of the world are waking up to the truth about the pharmaceutical business with disease. To learn about natural health approaches that have been scientifically shown to block all key mechanisms that make cancer a deadly disease, click here.

Epilepsy drug linked to tenfold increase in autism: researchers

January 31, 2013

Children born to mothers who took an epilepsy drug while pregnant are up to ten times more likely to suffer autism or similar conditions, a study has found.
Read article in the Daily Telegraph (UK)

Common antidepressant linked to heart rhythm risk

January 30, 2013

A widely prescribed antidepressant called citalopram may increase the risk of dangerous heart arrhythmias, US scientists have warned.
Read article at netdoctor.co.uk (UK)

Families face battle with GSK over dangerous diabetes drug

January 29, 2013

Thousands of families in the UK could be deprived of compensation for the death or harm of a relative caused by the diabetes drug Avandia, even though the British maker has agreed to pay billions of dollars to settle similar claims in the US.
Read article in the Guardian (UK)

Drug companies 'using Indians as guinea pigs'

January 27, 2013

India's Supreme Court has condemned the global pharmaceutical industry, claiming it has been using its citizens as ''guinea pigs''. The court has now restricted clinical drug trials throughout the country after hearing evidence that new, experimental medicines are being trialled on people, including children and the disabled, without their knowledge or permission.
Read article at theage.com.au (Australia)

Maker Hid Data About Design Flaw in Hip Implant, Records Show

January 25, 2013

Johnson & Johnson executives knew years before they recalled a troubled artificial hip in 2010 that it had a critical design flaw, but the company concealed that information from physicians and patients, according to internal documents disclosed on Friday during a trial related to the device’s failure.
Read article in the New York Times (USA)

Comment: Coming hot on the heels of reports suggesting it had hidden studies showing its Risperdal anti-psychotic pill caused diabetes, and its subsequently agreeing to pay as much as $2.2 billion to resolve an investigation into its marketing of the drug, including a $400 million criminal fine, the revelations in this trial are only the latest in a long line of scandals involving Johnson & Johnson. Notably, therefore, following several criminal investigations involving the company in recent years, and evidence suggesting it had hired contractors to conduct a clandestine recall of one of its products without notifying consumers of the potential problems, the company is reportedly now facing more than 10,000 lawsuits in the United States in connection with the flawed hip implant.

Study suggests link between regular aspirin use, increased risk of age-related macular degeneration

January 21, 2013

By obs/Bayer Vital GmbH

Regular aspirin use appears to be associated with an increased risk of neovascular age-related macular degeneration (AMD), which is a leading cause of blindness in older people, and it appears to be independent of a history of cardiovascular disease and smoking, according to a report published Online First by JAMA Internal Medicine.
Read article at medicalxpress.com

Comment: Additional research suggests that regular use of aspirin also increases the risk of developing Crohn's disease; irregular heart rhythm; erectile dysfunction and hearing loss. In one recent study, even low-dose aspirin was found to be associated with an increased risk of major gastrointestinal or cerebral bleeding.

German doctors shaken by corruption allegations

January 19, 2013

The German Medical Association has investigated nearly 1,000 cases of corrupt doctors over the past few years, according to its president, Frank Ulrich Montgomery. Dr Montgomery told Der Spiegel that more than half of the case involved alleged bribes from an Israeli pharmaceutical company, Ratiopharm.
Read article at bioedge.org (Australia)

Flushing Sound: Drug Disposal In Wisconsin Is Costly

January 16, 2013

As a growing number of governments, big and small, grapple with pharmaceutical waste, they are also struggling to pay for disposal programs. Last year, for instance, Alameda County in California passed an ordinance that requires drugmakers to pay for the disposal of unused and expired prescription medicines. The trade groups for the pharmaceutical industry responded by filing a lawsuit.
Read article at pharmalot.com

Drugmakers suffer decline in trust, report says

January 14, 2013

The overall corporate reputation of pharmaceutical companies declined in 2012 compared to 2011, according to an independent study by patients' organisations. The study - "The corporate reputation of pharma in 2012: the patient perspective" - is funded by PatientView, which represents 600 patient groups.
Read article at euractiv.com

Blood pressure and painkiller mix tied to kidney problems

January 8, 2013

People who take a combination of blood pressure drugs and certain painkillers are at increased risk for serious kidney problems that doctors should watch for, Canadian researchers say.
Read article on the CBC News website (Canada)

Parkinson's drugs linked to compulsive gambling and shopping not the disease itself: research

January 8, 2013

Compulsive shopping, gambling and cleaning associated with Parkinson's disease is actually caused by the drugs used to treat the disease, researchers have found.
Read article in the Daily Telegraph (UK)

Indian Court Wants Stricter Clinical Trial Oversight

January 7, 2013

Amid ongoing concern over the conduct of clinical trials in India and patient protection, the Indian Supreme Court has slammed regulators for shoddy oversight that is creating “havoc” and leading to the deaths of many citizens. In sharp remarks, the government was criticized for going into a “deep slumber” and failing to establish mechanisms to stop “rackets” of multinational drugmakers, which are allegedly conducting illegal clinical trials around the country, according to various media reports.
Read article at pharmalot.com

Trial set to begin in Boston over pregnancy drug

January 3, 2013

At first, the Melnick sisters thought it was just a cruel coincidence that two of them were diagnosed with breast cancer.  But when two more sisters were given the same diagnosis, they came to suspect that a drug their mother took in the 1950s while she was pregnant had something to do with it.
Read article at medicalxpress.com

Cholesterol Medicine Affects Energy Production in Muscles

January 3, 2013

Up to 75 per cent of patients who take statins to treat elevated cholesterol levels may suffer from muscle pain. Scientists at the Center for Healthy Aging at the University of Copenhagen have now identified a possible mechanism underlying this unfortunate side effect.
Read article at sciencedaily.com

Comment: The mechanism identified in this study, depletion of the cellular nutrient coenzyme Q10 by statin drugs, has been known about for some years now. In fact, as long ago as 1990, the drug company Merck actually patented a combination of a statin drug and Q10 as a means of counteracting it. To this day, however, it has never marketed any product containing the combination. To learn the facts about cholesterol drugs, click here. To learn how high cholesterol levels can be eradicated naturally, without drugs, click here.

Drug trials in India 'causing havoc to human life'

January 3, 2013

India's Supreme Court said Thursday that unregulated clinical trials of new drugs were causing "havoc" in the country as it ordered the health ministry to monitor any new applications for tests.
Read article at medicalxpress.com

Overmedicating Patients & Speaking For Drugmakers

January 2, 2013

A jury in upstate New York recently found that a doctor’s negligence caused a patient to commit suicide by overmedicating him with psychiatric drugs. As it turns out, the same doctor was also paid more than $200,000 by various drugmakers for more than a decade to promote some of the same psychiatric medicines to other doctors, The Syracuse Post-Standard reports.
Read article at pharmalot.com